Drugs / Horse Anti-human Thymocyte Globulin (h-ATG)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00426517 | Jan 2007 → Nov 2019 | immunodeficiency disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Horse Anti-human Thymocyte Globulin (h-ATG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00426517 ↗ |
| Route | Intravenous | “given intravenously” NCT00426517 ↗ |